Panahi, Y., Beiraghdar, F., Kashani, N., Baharie Javan, N., dadjo, Y. (2011). Comparison of Piascledine (Avocado and Soybean Oil) and Hormone Replacement Therapy in Menopausal-Induced Hot Flashing. Iranian Journal of Pharmaceutical Research, Volume 10(4), 941-951.
Yunes Panahi; Fatemeh Beiraghdar; Nafise Kashani; Nika Baharie Javan; yahya dadjo. "Comparison of Piascledine (Avocado and Soybean Oil) and Hormone Replacement Therapy in Menopausal-Induced Hot Flashing". Iranian Journal of Pharmaceutical Research, Volume 10, 4, 2011, 941-951.
Panahi, Y., Beiraghdar, F., Kashani, N., Baharie Javan, N., dadjo, Y. (2011). 'Comparison of Piascledine (Avocado and Soybean Oil) and Hormone Replacement Therapy in Menopausal-Induced Hot Flashing', Iranian Journal of Pharmaceutical Research, Volume 10(4), pp. 941-951.
Panahi, Y., Beiraghdar, F., Kashani, N., Baharie Javan, N., dadjo, Y. Comparison of Piascledine (Avocado and Soybean Oil) and Hormone Replacement Therapy in Menopausal-Induced Hot Flashing. Iranian Journal of Pharmaceutical Research, 2011; Volume 10(4): 941-951.
Comparison of Piascledine (Avocado and Soybean Oil) and Hormone Replacement Therapy in Menopausal-Induced Hot Flashing
1Chemical Injuries Research Center, Baqiyatallah Medical Sciences University, Tehran, Iran
2Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
3Faculty of Medicine, Department of Genecology, Baqiyatallah University of Medical Sciences, Tehran, Iran.
4Faculty of Pharmacy, Islamic Azad University, Tehran, Iran.
5Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Abstract
Different symptoms in Climacteric period, includes hot flash. Hormone replacement therapy (HRT) is common therapy for relief of menopausal symptoms but has possible contraindications and side effects. Recently Piascledine (combination of Avocado oil with Soybean oil) showed effects in reducing hot flash severity. Present study designed to compare the effects of HRT with Piascledine in treatment of hot flash. The cases of this study were sixty-six women at the age range of 40 to 70 years and complaints of menopause-induced hot flashing, whose last menstruation dated at least 6 months prior to the beginning of the study. The patients in this open label clinical trial, randomized to receive Piascledine capsule 1 mg or HRT (0.625 mg oral daily Conjugated Estrogen tablets, plus 2.5 mg continuous oral daily Medroxyprogesterone Acetate tablets) for 2 month. Hot flash property and severity was assessed via a daily check list and Visual analog scale. Climacteric symptom was measured before and after intervention using Greene Climacteric Scale (GCS) and Blatt-kupperman Menopausal Index (BKMI). Thirty-three eligible patients were allocated in each group. From the Piascledine group, one patient and from the HRT group, 16 patients weren›t willing to attend the study; therefore, 32 and 17 woman received treatment in Piascledine and HRT groups. 4 patients were withdrawn for vaginal bleeding and one for breast tenderness from HTR group. Hot flash severity in both groups decreased during the time similarly. With regard to GCS (p = 0.571) and BMKI (p = 0.891), the outcome was similar among the two groups. Due to low HRT compliance and its possible risks in long period of time and considering the same activity of soybean supplement and HRT in relieving the hot flash as menopausal symptoms in women, it seems that soybean supplements can be an alternative therapy to hormone.
Top